Cargando…

Genetic variation in KSHV encoded microRNAs affects microRNA expression and is associated with multicentric Castleman’s disease risk

Detalles Bibliográficos
Autores principales:	Marshall, Vickie, Ray, Alex, Han, Soo-Jin, Uldrick, Thomas, Barsov, Eugene, Quinones, Octavio, Leighty, Robert, Labo, Nazzarena, Wyvill, Kathy, Aleman, Karen, Polizzotto, Mark N, Little, Richard F, Ott, David, Yarchoan, Robert, Renne, Rolf, Whitby, Denise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330049/ http://dx.doi.org/10.1186/1750-9378-7-S1-O5

Ejemplares similares

Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions
por: Marshall, Vickie A., et al.
Publicado: (2018)

Heterogeneity and Breadth of Host Antibody Response to KSHV Infection Demonstrated by Systematic Analysis of the KSHV Proteome
por: Labo, Nazzarena, et al.
Publicado: (2014)

KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease
por: Polizzotto, Mark N, et al.
Publicado: (2010)

Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
por: Uldrick, Thomas, et al.
Publicado: (2010)

Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV
por: Uldrick, Thomas S, et al.
Publicado: (2012)

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2012)

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2017)

KSHV encoded miRNA single nucleotide polymorphisms identified in clinical samples can affect miRNA processing and level of expression
por: Marshall, Vickie, et al.
Publicado: (2012)

Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA
por: Gruffaz, Marion, et al.
Publicado: (2020)

T-cell responses to KSHV infection: a systematic approach
por: Roshan, Romin, et al.
Publicado: (2017)

[(18)F]-fluoro-D-deoxyglucose positron emission tomography findings in Kaposi sarcoma herpes virus associated multicentric Castleman disease: correlation with clinical, inflammatory, and virologic parameters
por: Polizzotto, Mark N, et al.
Publicado: (2012)

Profiling viral and host microRNA expression in cells infected with KSHV and EBV
por: Whitby, D, et al.
Publicado: (2009)

Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)
por: Yarchoan, R, et al.
Publicado: (2009)

Current epidemiology of KSHV infection in American men who have sex with men
por: Labo, Nazzarena, et al.
Publicado: (2010)

Identification of Cellular Genes Targeted by KSHV-Encoded MicroRNAs
por: Samols, Mark A, et al.
Publicado: (2007)

KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation
por: Kieffer-Kwon, Philippe, et al.
Publicado: (2015)

Variation in KSHV prevalence between geographically proximate locations in Uganda
por: Nalwoga, Angela, et al.
Publicado: (2020)

Upregulation of xCT by KSHV-Encoded microRNAs Facilitates KSHV Dissemination and Persistence in an Environment of Oxidative Stress
por: Qin, Zhiqiang, et al.
Publicado: (2010)

827. High KSHV Seroprevalence Among MSM with HIV Associated with Oral Intercourse and Methamphetamine Use in the Southern United States
por: Knights, Sheena, et al.
Publicado: (2021)

A Phase Ib Study of Sorafenib (BAY 43‐9006) in Patients with Kaposi Sarcoma
por: Uldrick, Thomas S., et al.
Publicado: (2017)

Emerging Themes from EBV and KSHV microRNA Targets
por: Ramalingam, Dhivya, et al.
Publicado: (2012)

A core laboratory for the generation of quality-controlled g-herpesvirus bacmids: generation of KSHV microRNA mutants
por: Krueger, Brian, et al.
Publicado: (2012)

Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda
por: Nalwoga, Angela, et al.
Publicado: (2023)

Comparison of Epstein–Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3–89 years from Uganda
por: Nalwoga, Angela, et al.
Publicado: (2023)

Malaria during pregnancy and transplacental transfer of Kaposi sarcoma-associated herpesvirus (KSHV) antibodies: a cohort study of Kenyan mother and child pairs
por: Sabourin, Katherine R., et al.
Publicado: (2020)

KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts
por: Qin, Zhiqiang, et al.
Publicado: (2012)

Systemically Circulating Viral and Tumor-Derived MicroRNAs in KSHV-Associated Malignancies
por: Chugh, Pauline E., et al.
Publicado: (2013)

Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma
por: Lurain, Kathryn, et al.
Publicado: (2022)

Evaluation of Non-Invasive Multispectral Imaging as a Tool for Measuring the Effect of Systemic Therapy in Kaposi Sarcoma
por: Kainerstorfer, Jana M., et al.
Publicado: (2013)

Characteristics of circulating KSHV-infected viroblasts during active KSHV(+) multicentric Castleman disease
por: Martin de Frémont, Gregoire, et al.
Publicado: (2022)

Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
por: Burbelo, Peter D, et al.
Publicado: (2010)

A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway
por: Li, Wan, et al.
Publicado: (2016)

KSHV MicroRNAs Mediate Cellular Transformation and Tumorigenesis by Redundantly Targeting Cell Growth and Survival Pathways
por: Moody, Rosalie, et al.
Publicado: (2013)

Dendritic cell-mediated infection of primary B cells with KSHV
por: Bagni, R, et al.
Publicado: (2009)

Circulating microRNA, secreted microRNA and exogenous plant microRNA
por: Zhang, Chenyu
Publicado: (2012)

Correction: KSHV MicroRNAs Mediate Cellular Transformation and Tumorigenesis by Redundantly Targeting Cell Growth and Survival Pathways
por: Moody, Rosalie, et al.
Publicado: (2014)

Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling
por: Choi, Hong Seok, et al.
Publicado: (2015)

Genome-Wide Sequence Analysis of Kaposi Sarcoma-Associated Herpesvirus Shows Diversification Driven by Recombination
por: Sallah, Neneh, et al.
Publicado: (2018)

Kaposi’s sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda
por: Nalwoga, Angela, et al.
Publicado: (2021)

Contemporary Ribonomics Methods for Viral microRNA Target Analysis
por: Gay, Lauren A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pb2jbr314kvjpjpo5ujp9emp5r